Sapient Capital LLC Has $1.66 Million Stake in UnitedHealth Group Incorporated $UNH

Key Points

• Sapient Capital LLC significantly reduced its stake in UnitedHealth Group by 97%, selling 169,549 shares, leaving it with only 5,322 shares worth approximately $1.66 million.
• Institutional investors collectively hold about 87.86% of UnitedHealth Group's stock, with major players like Vanguard Group Inc. and Wellington Management Group LLP increasing their holdings in the company.
• UnitedHealth reported a $4.08 EPS for the last quarter, falling short of analyst expectations, while the company's revenue increased by 12.9% year-over-year to $111.62 billion.

Sapient Capital LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 97.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,322 shares of the healthcare conglomerate's stock after selling 169,549 shares during the period. Sapient Capital LLC's holdings in UnitedHealth Group were worth $1,660,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in UNH. Bayforest Capital Ltd grew its position in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its position in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 50 shares in the last quarter. Copia Wealth Management purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $42,000. IAG Wealth Partners LLC purchased a new position in UnitedHealth Group during the 1st quarter worth approximately $42,000. Finally, Investment Management Corp VA ADV purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $44,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Up 0.6%

Shares of NYSE:UNH traded up $1.90 during midday trading on Friday, reaching $336.72. 13,528,738 shares of the company were exchanged, compared to its average volume of 13,748,202. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a fifty day simple moving average of $295.67 and a two-hundred day simple moving average of $364.42. The firm has a market cap of $304.96 billion, a PE ratio of 14.59, a P/E/G ratio of 2.20 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period last year, the firm earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Barclays boosted their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a report on Thursday, September 4th. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a research note on Friday, September 12th. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Bank of America lifted their price objective on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research note on Monday, August 18th. Finally, Oppenheimer decreased their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.